its possible many traders are scared to buy them into the prioty review is passed and other things, but the drug has a very good percentage of being approved so im very confident in the stock just like i am with NEPH for the last 6 months and it hasnt wavered much, and if you look at NEPH and CTIC there charts look pretty smiliar and they will look alot more similiar after monday's news for CTIC..
Market Data 
Markets 
AI
